Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. 2001

J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
Laboratorio Multidisciplinario de Investigación, Escuela Militar de Graduados de Sanidad y Escuela Médico Militar, Universidad del Ejército y Fuerza Aérea, México D.F. jaimeberumen@hotmail.com

BACKGROUND Human papillomavirus 16 (HPV16) has a number of variants, each with a different geographic distribution and some that are associated more often with invasive neoplasias. We investigated whether the high incidence of cervical cancer in Mexico (50 cases per 100 000 women) may be associated with a high prevalence of oncogenic HPV16 variants. METHODS Cervical samples were collected from 181 case patients with cervical cancer and from 181 age-matched control subjects, all from Mexico City. HPV16 was detected with an E6/E7 gene-specific polymerase chain reaction, and variant HPV classes and subclasses were identified by sequencing regions of the E6 and L1/MY genes. Clinical data and data on tumor characteristics were also collected. All statistical tests were two-sided. RESULTS HPV16 was detected in cervical scrapes from 50.8% (92 of 181) of case patients and from 11% (20 of 181) of control subjects. All HPV16-positive samples, except one, contained European (E) or Asian-American (AA) variants. AA and E variants were found statistically significantly more often in case patients (AA = 23.2% [42 of 181]; E = 27.1% [49 of 181]) than in control subjects (AA = 1.1% [two of 181]; E = 10% [18 of 181]) (P<.001 for case versus control subjects for either E or AA variants, chi2 test). However, the frequency of AA variants was 21 times higher in cancer patients than in control subjects, whereas that ratio for E variants was only 2.7 (P =.006, chi2 test). The odds ratio (OR) for cervical cancer associated with AA variants (OR = 27.0; 95% confidence interval [CI] = 6.4 to 113.7) was higher than that associated with E variants (OR = 3.4; 95% CI = 1.9 to 6.0). AA-positive case patients (46.2 +/- 12.5 years [mean +/- standard deviation]) were 7.7 years younger than E-positive case patients (53.9 +/- 12.2 years) (P =.004, Student's t test). AA variants were associated with squamous cell carcinomas and adenocarcinomas, but E variants were associated with only squamous cell carcinomas (P =.014, Fisher's exact test). CONCLUSIONS The high frequency of HPV16 AA variants, which appear to be more oncogenic than E variants, might contribute to the high incidence of cervical cancer in Mexico.

UI MeSH Term Description Entries
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
February 2001, Journal of the National Cancer Institute,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
January 2016, Virology,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
October 2003, International journal of cancer,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
August 1991, International journal of cancer,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
January 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
March 1996, BMJ (Clinical research ed.),
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
December 2005, Gynecologic oncology,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
September 2013, Journal of medical virology,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
December 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
J Berumen, and R M Ordoñez, and E Lazcano, and J Salmeron, and S C Galvan, and R A Estrada, and E Yunes, and A Garcia-Carranca, and G Gonzalez-Lira, and A Madrigal-de la Campa
December 2007, Journal of medical virology,
Copied contents to your clipboard!